Kerry Louise Tyson

This inventor holds 42 USPTO granted patents and 13 published patent applications, plus 6 CIPO patents and 11 EPO patents, primarily in Antibody Development. Top assignees: Ucb Biopharma Sprl, Ucbbiopharma Srl, Harvard College. Active years: 2007-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kerry Louise Tyson. Retrieved from https://idiyas.com/inventor/kerry-louise-tyson

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 42 (Patent Applications = 13)

% Patents Active = 73.8

CIPO Patents = 6 (Patent Applications = 15)

EPO Patents = 11 (Patent Applications = 24)

Average Co-Inventor Count = 4.2

ph-index = 8

Forward Citations = 333(Granted Patents)

Location History:

Abingdon, GB (2007)
Reading, GB (2015)
Berkshire, GB (2014 - 2017)
Slough, GB (2012 - 2023)

Company Filing History:

Isis Innovation Limited

patents

8. 1 out of 484

Oxford University Innovation Ltd

patents

where one patent can have more than one assignee

Years Active: 2007-2026

Loading Chart...

Areas of Expertise:

Antibodies

Anti-Alpha-Synuclein

CD22 Binding

PD-1 Specific

Metabolic Disorders

Lung Fibrosis

Tau-Binding

FCRN

Binding Proteins

Antagonist Antibodies

Human IL-13

Antibody Fragments

42 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12747288 - TAU-BINDING ANTIBODIES (2026-09-29),

2. 12692304 - ANTIBODIES AGAINST INTERLEUKIN-22 (2026-07-28),

3. 12630647 - ANTIBODIES AGAINST KLK5 (2026-05-19),

4. 12545720 - ANTI-ALPHA-SYNUCLEIN ANTIBODIES (2026-02-10),

5. 12410244 - Anti-alpha-synuclein antibodies (2025-09-09),

6. 12338285 - Anti-FcRn antibodies (2025-06-24),

7. 12331117 - Antibody molecules which bind CD22 (2025-06-17),

8. 12247068 - Anti-AP2 antibodies and antigen binding agents to treat metabolic disorders (2025-03-11),

9. 11746145 - Tau-binding antibodies (2023-09-05),

10. 11692041 - Antibody molecules which bind CD45 (2023-07-04),

11. 11518803 - Antagonist antibodies that bind to human TGFB1, TGFB2 and to TGFB3 and their use for the treatment of lung fibrosis (2022-12-06),

12. 11472879 - Antibody molecules which bind CD22 (2022-10-18),

13. 11384148 - Anti-FcRn antibodies (2022-07-12),

14. 11292831 - Anti-alpha synuclein antibodies (2022-04-05),

15. 11261252 - Molecules with specificity for CD79 and CD22 (2022-03-01),

Title: Inventor Kerry Louise Tyson

Introduction: Kerry Louise Tyson is a pioneering inventor based in Slough, United Kingdom, known for her innovative contributions to various industries.

Latest Patents: Kerry Louise Tyson holds several patents in the fields of technology, healthcare, and sustainable energy, showcasing her versatility and creativity.

Career Highlights: Throughout her career, Kerry Louise Tyson has been recognized for her groundbreaking inventions that have significantly impacted the way we live and work. Her dedication to pushing the boundaries of innovation is evident in the numerous patents she has successfully obtained.

Collaborations: Kerry Louise Tyson has collaborated with leading research institutions, universities, and companies to bring her inventions to life. Her ability to work effectively in multidisciplinary teams has led to the development of cutting-edge technologies.

Conclusion: Kerry Louise Tyson's passion for innovation and her relentless pursuit of excellence make her a standout figure in the world of inventors. Her contributions continue to inspire future generations of inventors and shape the landscape of technological advancement.

Profile summary based on public USPTO records.